Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
- PMID: 25704013
- PMCID: PMC4489701
- DOI: 10.1016/j.jphs.2014.12.013
Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting spinal cord motoneurons (MN) with an associative connection to Frontotemporal Lobar Dementia (FTLD). The endoplasmic reticulum (ER) bound Sigma-1 Receptor (S1R) chaperone protein localizes to specialized ER cisternae within 10 nm of the plasma membrane in spinal cord ventral horn cholinergic post synaptic C-terminals. Removal of the S1R gene in the Superoxide Dismutase-1 (SOD-1) mouse model of ALS exacerbated the neurodegenerative condition and resulted in a significantly reduced longevity when compared to the SOD-1/S1R wild type (WT) mouse. The proposed amelioration of the ALS phenotype by the S1R is likely due to a "brake" on excitation of the MN as evidenced by a reduction in action potential generation in the MN of the WT when compared to the S1R KO mouse MN. Although the precise signal transduction pathway(s) regulated by the S1R in the MN has/have not been elucidated at present, it is likely that direct or indirect functional interactions occur between the S1R in the ER cisternae with voltage gated potassium channels and/or with muscarinic M2 receptor signaling in the post synaptic plasma membrane. Possible mechanisms for regulation of MN excitability by S1R are discussed.
Keywords: ALS; C-terminals; Motoneurons; Sigma-1 receptor.
Copyright © 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. All rights reserved.
Conflict of interest statement
All authors declare no conflict of interest.
Figures



Similar articles
-
The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS?Adv Exp Med Biol. 2017;964:255-265. doi: 10.1007/978-3-319-50174-1_17. Adv Exp Med Biol. 2017. PMID: 28315276 Review.
-
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.Neurobiol Dis. 2014 Feb;62:218-32. doi: 10.1016/j.nbd.2013.10.010. Epub 2013 Oct 16. Neurobiol Dis. 2014. PMID: 24141020
-
Lack of sigma-1 receptor exacerbates ALS progression in mice.Neuroscience. 2013 Jun 14;240:129-34. doi: 10.1016/j.neuroscience.2013.02.035. Epub 2013 Feb 28. Neuroscience. 2013. PMID: 23458708 Free PMC article.
-
[Protective function of sigma-1 receptor in spinal cord motor neurons].Tsitologiia. 2013;55(5):285-9. Tsitologiia. 2013. PMID: 24592734 Review. Russian.
-
Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis.Hum Mol Genet. 2020 Mar 13;29(4):529-540. doi: 10.1093/hmg/ddz267. Hum Mol Genet. 2020. PMID: 31696229
Cited by
-
Sigma-1 receptor: culprit and rescuer in motor neuron diseases.Neural Regen Res. 2021 Jan;16(1):106-107. doi: 10.4103/1673-5374.286961. Neural Regen Res. 2021. PMID: 32788456 Free PMC article. No abstract available.
-
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33.Front Chem. 2019 Jul 11;7:496. doi: 10.3389/fchem.2019.00496. eCollection 2019. Front Chem. 2019. PMID: 31355187 Free PMC article.
-
Structure-Based Modeling of Sigma 1 Receptor Interactions with Ligands and Cholesterol and Implications for Its Biological Function.Int J Mol Sci. 2023 Aug 19;24(16):12980. doi: 10.3390/ijms241612980. Int J Mol Sci. 2023. PMID: 37629160 Free PMC article.
-
APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum.Oncotarget. 2017 May 16;8(31):51317-51330. doi: 10.18632/oncotarget.17906. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881650 Free PMC article.
-
Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.Sci Transl Med. 2019 Feb 6;11(478):eaau5266. doi: 10.1126/scitranslmed.aau5266. Sci Transl Med. 2019. PMID: 30728287 Free PMC article.
References
-
- Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39–59. - PubMed
-
- Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. 2012;33:1345–1351. - PubMed
-
- Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011;70:913–919. - PubMed
-
- Marin B, Kacem I, Diagana M, Boulesteix M, Gouider R, Preux PM, et al. Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review. Amyotroph Lateral Scler. 2012;13:276–283. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous